[RobinP]

Thanks for the post, Lani. You can see my comments on the stats for very early stage her2 bc on the other recent threads concerning this on this board. You know, we all had a good idea that the relapse for node negative her2+ hormonal negatives was poor from the 2005 HERA trial and that is the reason that I ultimately sought late Herceptin. Neil Spector, head investigator for Lapatinb, actually consulted with me and convinced me to do the 9 week regimen of Herceptin like the Finnish Trial. Yep, I don't regret doing it one bit now.

PS Still we don't have a clear idea if there is a difference in prognosis for T1a and T1b, as these two variables were not isolated well, nor was hormonal status with her2.